Survival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate Cancer
Open Access
- 9 July 2008
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 300 (2), 173-181
- https://doi.org/10.1001/jama.300.2.173
Abstract
Prostate cancer is the most common nonskin cancer and the second most common cause of cancer death among men.1 For the majority of men with incident prostate cancer (approximately 85%), disease is diagnosed at localized (T1-T2) stages,2 and standard treatment options include surgery, radiation, or conservative management (ie, deferral of treatment until necessitated by disease signs or symptoms).This publication has 47 references indexed in Scilit:
- Analysis of Observational Studies in the Presence of Treatment Selection BiasJAMA, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate CancerJournal of Clinical Oncology, 2006
- Determinants of Androgen Deprivation Therapy Use for Prostate Cancer: Role of the UrologistJNCI Journal of the National Cancer Institute, 2006
- Immediate or Deferred Androgen Deprivation for Patients With Prostate Cancer Not Suitable for Local Treatment With Curative Intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891Journal of Clinical Oncology, 2006
- Trends in primary androgen depletion therapy for patients with localized and locally advanced prostate cancer: Japanese perspectiveCancer Science, 2006
- HYPOGONADISM AND METABOLIC SYNDROME: IMPLICATIONS FOR TESTOSTERONE THERAPYJournal of Urology, 2005
- Androgens, insulin resistance and vascular disease in menClinical Endocrinology, 2005
- Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate CancerThe New England Journal of Medicine, 1999
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992